Rising Biosciences (Rising Biosciences) Sale Of Property, Plant, Equipment : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Sale Of Property, Plant, Equipment?

Rising Biosciences's sale of property, plant, equipment for the three months ended in . 20 was $0.00 Mil. It means Rising Biosciences gained $0.00 Mil from selling property, plant, and equipment.

Compared with last quarter ($0.00 Mil in . 20 ), Rising Biosciences gained the same money from selling property, plant, and equipment in . 20 ($0.00 Mil).

Rising Biosciences Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Rising Biosciences's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Sale Of Property, Plant, Equipment Chart

Rising Biosciences Annual Data

Trend

Sale Of Property, Plant, Equipment

Rising Biosciences Quarterly Data

Sale Of Property, Plant, Equipment

Rising Biosciences Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Rising Biosciences Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Sale Of Property, Plant, Equipment

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.